ARUP Labs Partners with CDC to Develop H5N1 Test
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
Read MorePosted by Andy Lundin | Sep 16, 2024 | Emerging & Zoonotic Diseases |
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
Read MorePosted by Andy Lundin | Sep 16, 2024 | Emerging & Zoonotic Diseases |
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Cardiovascular |
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Read MorePosted by Andy Lundin | Sep 12, 2024 | Digital Pathology |
Proscia’s AI-powered digital pathology software enhances pathologists’ ability to deliver more precise and efficient cancer diagnoses.
Read MorePosted by Andy Lundin | Sep 9, 2024 | Diagnostic Technologies |
Researchers developed machine learning models to diagnose pediatric inflammatory conditions by analyzing cell-free RNA in blood plasma.
Read More